Literature DB >> 4270890

Cardiac ultrastructural changes induced by daunorubicin therapy.

L M Buja, V J Ferrans, R J Mayer, W C Roberts, E S Henderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4270890     DOI: 10.1002/1097-0142(197310)32:4<771::aid-cncr2820320407>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  40 in total

1.  Inhibition of adriamycin cardiotoxicity by acetyldaunomycin.

Authors:  G Zbinden
Journal:  Experientia       Date:  1975-09-15

2.  Significance of adaptation mechanisms in adriamycin induced congestive heart failure.

Authors:  P K Singal; N Siveski-Iliskovic; N Kaul; M Sahai
Journal:  Basic Res Cardiol       Date:  1992 Nov-Dec       Impact factor: 17.165

3.  Anthracycline treatment and ventricular remodeling in left ventricular assist device patients.

Authors:  Ana Maria Segura; Rajko Radovancevic; Zumrat T Demirozu; O H Frazier; L Maximilian Buja
Journal:  Tex Heart Inst J       Date:  2015-04-01

4.  Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain.

Authors:  R Tanaka; Y Iwasaki; H Koprowski
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

5.  Neoplasms involving the heart, their simulators, and adverse consequences of their therapy.

Authors:  W C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-10

6.  Lipid lowering: an important factor in preventing adriamycin-induced heart failure.

Authors:  N Iliskovic; P K Singal
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 7.  Doxorubicin cardiomyopathy.

Authors:  Kanu Chatterjee; Jianqing Zhang; Norman Honbo; Joel S Karliner
Journal:  Cardiology       Date:  2009-12-11       Impact factor: 1.869

8.  Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stress.

Authors:  N Iliskovic; T Li; N Khaper; V Palace; P K Singal
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

9.  Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity.

Authors:  B Lantz; J Adolfsson; B Lagerlöf; P Reizenstein
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

10.  Naproxen aggravates doxorubicin-induced cardiomyopathy in rats.

Authors:  Rahila Ahmad Pathan; Bhulan Kumar Singh; K K Pillai; Kiran Dubey
Journal:  Indian J Pharmacol       Date:  2010-02       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.